NeoGenomics, Inc. announced on January 17, 2022, Kevin Johnson provided notice of his resignation from the Board of Directors of the Company, effective as of January 17, 2022. Following the resignation, the Board reduced its size from nine to eight directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.87 USD | +3.97% | +5.32% | -14.28% |
05-28 | NeoGenomics, Inc. to Introduce Comprehensive Lung Solution & Feature Hematopathology Services At ASCO | CI |
05-02 | North American Morning Briefing : Stock Futures -3- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.28% | 1.77B | |
-18.02% | 8.43B | |
+69.46% | 4.35B | |
+7.88% | 2.78B | |
-1.93% | 2.64B | |
-56.54% | 1.74B | |
-16.69% | 1.48B | |
+17.87% | 1.22B | |
-49.60% | 1.02B | |
+10.83% | 922M |
- Stock Market
- Equities
- NEO Stock
- News NeoGenomics, Inc.
- Neogenomics, Inc. Announces Resignation of Kevin Johnson from Board of Directors